908 Devices (NASDAQ: MASS) revenue
908 Devices reported revenue of $56.2m for fiscal 2025, 17.7% more than in fiscal 2024 ($47.7m). Since fiscal 2020 its revenue has grown by 109.0%, an average growth of 15.9% a year.
Fiscal 2025 is the highest of the 6 fiscal years on record for 908 Devices. The biggest drop was in fiscal 2024, −4.9%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $56.2m | +17.7% | −$39.4m | −70.1% |
| 2024 | $47.7m | −4.9% | −$57.4m | −120.2% |
| 2023 | $50.2m | +7.2% | −$42.8m | −85.1% |
| 2022 | $46.9m | +11.0% | −$35.4m | −75.5% |
| 2021 | $42.2m | +56.9% | −$22.1m | −52.3% |
| 2020 | $26.9m | — | −$5.8m | −21.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
908 Devices revenue compared with its sector
By revenue for its latest fiscal year, 908 Devices ranks 322nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; 908 Devices, 17.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 320th | Tango Therapeutics | $62.4m | 48.3% |
| 321st | CVRX | $56.7m | 10.4% |
| 322nd | 908 Devices | $56.2m | 17.7% |
| 323rd | Nektar Therapeutics | $55.2m | −43.9% |
| 324th | Agios Pharmaceuticals | $54.0m | 48.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of 908 Devices
- How much revenue did 908 Devices make in fiscal 2025?
- 908 Devices reported revenue of $56.2m for fiscal 2025, compared with $47.7m in fiscal 2024.
- How much has the revenue of 908 Devices grown?
- Between fiscal 2020 and fiscal 2025 it went from $26.9m to $56.2m: 109.0% more, an average growth of 15.9% a year.
- What was the best year for revenue at 908 Devices?
- Of its last 6 fiscal years, fiscal 2025, with $56.2m.
- Where does 908 Devices rank in its sector by revenue?
- It ranks 322nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for 908 Devices come from?
- From the annual report (Form 10-K) that 908 Devices files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that 908 Devices files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on 908 Devices: the 908 Devices page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.